Health care industry
Proteomics International's PromarkerD Diabetes Test Gets Key Breakthrough in US Market
Proteomics International is making significant strides in bringing its PromarkerD diabetes-related blood test to the US market. The company has successfully secured an American Medical Association PLA billing code, allowing doctors to order and facilities to bill for the test, a crucial step towards broader market adoption. This breakthrough comes